Ares Acquisition Corp III
Historical Data
View all| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jul 3, 2026 | $192.23 | $194.56 | $183.73 | $185.64 | 8.59M |
| Jul 2, 2026 | $183.32 | $196.40 | $174.40 | $192.23 | 10.60M |
| Jul 1, 2026 | $170.91 | $185.66 | $166.88 | $183.32 | 12.36M |
| Jun 30, 2026 | $161.01 | $173.67 | $154.62 | $170.91 | 10.34M |
| Jun 29, 2026 | $161.73 | $164.93 | $158.23 | $161.01 | 10.42M |
| Jun 28, 2026 | $166.39 | $168.47 | $159.52 | $161.73 | 7.33M |
| Jun 27, 2026 | $173.36 | $179.52 | $161.66 | $166.39 | 9.92M |
| Jun 26, 2026 | $174.70 | $176.07 | $171.61 | $173.36 | 11.99M |
Company Overview
Ares Acquisition Corp III operates in the healthcare space within the Healthcare sector. The company generates the majority of its revenue from operating momentum, and has built a durable competitive position through scale, brand, and continued reinvestment. It serves customers globally and is headquartered in the United States. Reported figures on this page are generated for demonstration and are not investment advice.
Leadership
Board 14 · Independent 13 of 14| Date | Firm | Target | Rating |
|---|---|---|---|
| Jul 1 | Mizuho | $167.76 | Strong Buy |
| Jun 30 | Citi | $185.34 | Hold |
| Jun 24 | Piper Sandler | — | Hold |
| May 31 | Rosenblatt | — | Overweight |
| May 24 | Tigress Financial | $210.75 | Reduce |
| May 22 | Rosenblatt | $189.94 | Overweight |
Politician Trades
View allWhat's Happening Right Now
- Aug 20, 2026 · Listing ↗ — Ares Acquisition Corp III's units began separate trading of shares and warrants as of August 20, 2026.
- Aug 13, 2026 · Ownership ↗ — AQR reported a 5.8% stake in AAC, holding 2,000,000 units, as of August 13, 2026.
- Jul 7, 2026 · Ownership ↗ — Millennium entities disclosed a 5.3% stake in AAC, holding 2.105 million shares, as of July 7, 2026.
- Aug 27, 2026 · Analyst ↗ — A stock quote and forecast piece on AAC's shares was published on August 27, 2026.
Snapshot
Ares Acquisition Corp III is a special purpose acquisition company (SPAC) with no Form 10-K on file, meaning no revenue, profit, or balance-sheet figures are currently available for review. Recent activity centers on corporate and ownership structure rather than operating performance: its units began trading separately into component shares and warrants in August 2026, and several institutional holders—including AQR (5.8%) and Millennium entities (5.3%)—have disclosed sizable stakes. As a pre-merger blank-check vehicle, AAC's value is tied to its trust account and the prospects of an eventual business combination rather than any underlying operating business. No guidance, earnings, or financial performance data are available to assess at this time.
Bottom Line
AAC remains a pure structural/SPAC play with no operating financials to evaluate, so the investment case hinges entirely on trust-account value and expectations for a future merger target rather than fundamentals. Notable institutional accumulation by AQR and Millennium suggests some market interest in the vehicle ahead of a deal, but investors are essentially betting on deal-making outcomes and warrant/share dynamics rather than any disclosed business performance. Lack of financial disclosure means this remains a speculative, event-driven holding until a target is announced and reported.